Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Maitland · SciRah

Researcher profile · Semantic Scholar

M. Maitland

Share profile

M. Maitland — researcher profile on SciRah

h-index: 32
Works: 124
Citations: 5,966

Most-cited papers

CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis.
J. Gillmore, E. Gane, J. Taubel, J. Kao +22 more
2021New England Journal of Medicine1,252 citations Open access
Semantic Scholar
Inflammation, growth factors, and pulmonary vascular remodeling.
P. Hassoun, L. Mouthon, J. Barberà, S. Eddahibi +13 more
2009Journal of the American College of Cardiology715 citations Open access
Semantic Scholar
Initial Assessment, Surveillance, and Management of Blood Pressure in Patients Receiving Vascular Endothelial Growth Factor Signaling Pathway Inhibitors
M. Maitland, G. Bakris, H. Black, Helen X. Chen +9 more
2010Journal of the National Cancer Institute402 citations Open access
Semantic Scholar
Carboplatin and Paclitaxel in combination with either vorinostat or placebo for first-line therapy of advanced non-small-cell lung cancer.
S. Ramalingam, M. Maitland, P. Frankel, A. Argiris +7 more
2010Journal of Clinical Oncology263 citations Open access
Semantic Scholar
Cancer pharmacogenomics: strategies and challenges
H. Wheeler, M. Maitland, M. E. Dolan, Nancy J. Cox +1 more
2012Nature reviews genetics211 citations Open access
Semantic Scholar
Ambulatory monitoring detects sorafenib-induced blood pressure elevations on the first day of treatment
M. Maitland, K. Kasza, T. Karrison, K. Moshier +6 more
2009Clinical Cancer Research171 citations Open access
Semantic Scholar
A proposed EGFR inhibitor dermatologic adverse event-specific grading scale from the MASCC skin toxicity study group
M. Lacouture, M. Maitland, S. Segaert, A. Setser +16 more
2010Supportive Care in Cancer159 citations
Semantic Scholar
Dose-finding and pharmacokinetic study to optimize the dosing of irinotecan according to the UGT1A1 genotype of patients with cancer.
F. Innocenti, R. Schilsky, J. Ramírez, L. Janisch +10 more
2014Journal of Clinical Oncology143 citations Open access
Semantic Scholar
Management of cardiac toxicity in patients receiving vascular endothelial growth factor signaling pathway inhibitors.
R. Steingart, G. Bakris, Helen X. Chen, Ming-Hui Chen +9 more
2012American Heart Journal110 citations
Semantic Scholar
A Dosing/Cross-Development Study of the Multikinase Inhibitor Sorafenib in Patients With Pulmonary Arterial Hypertension
M. Gomberg-Maitland, M. Maitland, R. Barst, L. Sugeng +6 more
2009Clinical pharmacology and therapy101 citations Open access
Semantic Scholar
RECIST: no longer the sharpest tool in the oncology clinical trials toolbox---point.
Manish R. Sharma, M. Maitland, M. Ratain
2012Cancer Research86 citations Open access
Semantic Scholar
First-in-Human Study of PF-06647020 (Cofetuzumab Pelidotin), an Antibody–Drug Conjugate Targeting Protein Tyrosine Kinase 7, in Advanced Solid Tumors
M. Maitland, J. Sachdev, Manish R. Sharma, V. Moreno +14 more
2021Clinical Cancer Research68 citations Open access
Semantic Scholar
Phase 1 Studies of Sirolimus Alone or in Combination with Pharmacokinetic Modulators in Advanced Cancer Patients
E. Cohen, Ke-Hua Wu, C. Hartford, M. Kocherginsky +12 more
2012Clinical Cancer Research68 citations Open access
Semantic Scholar
Clinical Trials in the Era of Personalized Oncology
M. Maitland, R. Schilsky
2011Ca65 citations Open access
Semantic Scholar
PharmGKB summary: Sorafenib Pathways
L. Gong, Marilyn M. Giacomini, Craig P. Giacomini, M. Maitland +2 more
2017Pharmacogenetics & Genomics59 citations Open access
Semantic Scholar
Personalized treatment of lung cancer.
R. Salgia, T. Hensing, N. Campbell, A. Salama +4 more
2011Seminars in Oncology47 citations
Semantic Scholar
Analysis of the Yield of Phase II Combination Therapy Trials in Medical Oncology
M. Maitland, C. Hudoba, Kelly L. Snider, M. Ratain
2010Clinical Cancer Research47 citations Open access
Semantic Scholar
Multi-kinase inhibitors induce cutaneous toxicity through OAT6-mediated uptake and MAP3K7-driven cell death
E. Zimmerman, A. Gibson, Shui-Ying Hu, A. Vasilyeva +10 more
2015Cancer Research46 citations Open access
Semantic Scholar
Two Drug Interaction Studies of Sirolimus in Combination with Sorafenib or Sunitinib in Patients with Advanced Malignancies
T. Gangadhar, E. Cohen, Ke-Hua Wu, L. Janisch +8 more
2011Clinical Cancer Research46 citations Open access
Semantic Scholar
Sunitinib, Hypertension, and Heart Failure: A Model for Kinase Inhibitor-Mediated Cardiotoxicity
Rajesh Gupta, M. Maitland
2011Current Hypertension Reports46 citations
Semantic Scholar
Evaluation of food effect on pharmacokinetics of vismodegib in advanced solid tumor patients
Manish R. Sharma, T. Karrison, Bethany Kell, Ke-Hua Wu +9 more
2013Clinical Cancer Research40 citations Open access
Semantic Scholar
PF-06647020 (PF-7020), an antibody-drug conjugate (ADC) targeting protein tyrosine kinase 7 (PTK7), in patients (pts) with advanced solid tumors: Results of a phase I dose escalation and expansion study.
J. Sachdev, M. Maitland, Manish R. Sharma, V. Moreno +13 more
201838 citations
Semantic Scholar
Kinase Inhibition-Related Adverse Events Predicted from in vitro Kinome and Clinical Trial Data
X. Yang, Yong Huang, Matthew G. Crowson, Jianrong Li +2 more
2010Journal of Biomedical Informatics37 citations Open access
Semantic Scholar
First-in-human study of the antibody DR5 agonist DS-8273a in patients with advanced solid tumors
A. Forero, J. Bendell, Prasanna Kumar, L. Janisch +6 more
2017Investigational new drugs33 citations
Semantic Scholar
Pertuzumab Plus Trastuzumab in Patients With Endometrial Cancer With ERBB2/3 Amplification, Overexpression, or Mutation: Results From the TAPUR Study
E. Ahn, M. Rothe, P. Mangat, E. Garrett-Mayer +14 more
2023JCO Precision Oncology32 citations
Semantic Scholar
Identification of a variant in KDR associated with serum VEGFR2 and pharmacodynamics of pazopanib
M. Maitland, Chun-Fang Xu, Yu-Ching Cheng, E. Kistner-Griffin +17 more
2014Clinical Cancer Research30 citations Open access
Semantic Scholar
Sorafenib inhibits neuroblastoma cell proliferation and signaling, blocks angiogenesis, and impairs tumor growth
Nisha C. Kakodkar, Radhika Peddinti, Yu-Feng Tian, L. Guerrero +5 more
2012Pediatric Blood & Cancer29 citations
Semantic Scholar
Resampling phase III data to assess phase II trial designs and endpoints
Manish R. Sharma, T. Karrison, Yu-Yan Jin, R. Bies +3 more
2012Clinical Cancer Research29 citations Open access
Semantic Scholar
Pharmacokinetics and safety of vismodegib in patients with advanced solid malignancies and hepatic impairment
G. Abou-Alfa, L. Lewis, P. LoRusso, M. Maitland +6 more
2017Cancer Chemotherapy and Pharmacology28 citations Open access
Semantic Scholar
First-in-human, open-label dose-escalation and dose-expansion study of the safety, pharmacokinetics, and antitumor effects of an oral ALK inhibitor ASP3026 in patients with advanced solid tumors
Tian-Hong Li, P. LoRusso, M. Maitland, S. Ou +5 more
2016Journal of Hematology & Oncology28 citations Open access
Semantic Scholar
PF-06939999, a potent and selective PRMT5 inhibitor, in patients with advanced or metastatic solid tumors: A phase 1 dose escalation study.
Jordi Rodon Ahnert, C. Perez, Kit Wong, M. Maitland +9 more
202127 citations
Semantic Scholar
Comparing RECIST 1.1 and iRECIST in Advanced Melanoma Patients Treated with pembrolizumab in a Phase II Clinical Trial
F. Ahmed, L. Dercle, G. Goldmacher, Hao Yang +9 more
2020European Radiology27 citations Open access
Semantic Scholar
Enhanced detection of treatment effects on metastatic colorectal cancer with volumetric CT measurements for tumor burden growth rate evaluation
M. Maitland, J. Wilkerson, S. Karovic, Binsheng Zhao +14 more
2020Clinical Cancer Research27 citations Open access
Semantic Scholar
Vascular endothelial growth factor pathway
M. Maitland, X. Lou, J. Ramírez, A. Desai +6 more
2010Pharmacogenetics & Genomics26 citations Open access
Semantic Scholar
Safety, activity, and pharmacokinetics of an oral anaplastic lymphoma kinase (ALK) inhibitor, ASP3026, observed in a “fast follower” phase 1 trial design.
M. Maitland, S. Ou, A. Tolcher, P. LoRusso +6 more
201425 citations
Semantic Scholar
Predicting Response to Histone Deacetylase Inhibitors Using High-Throughput Genomics.
P. Geeleher, A. Loboda, Divya Lenkala, Fan Wang +8 more
2015Journal of the National Cancer Institute22 citations Open access
Semantic Scholar
Clinical pharmacodynamic/exposure characterisation of the multikinase inhibitor ilorasertib (ABT-348) in a phase 1 dose-escalation trial
M. Maitland, S. Piha-Paul, G. Falchook, R. Kurzrock +13 more
2018British Journal of Cancer21 citations Open access
Semantic Scholar
Tumor dynamic model-based decision support for Phase Ib/II combination studies: A retrospective assessment based on resampling of the Phase III study IMpower150
R. Bruno, M. Marchand, Kenta Yoshida, P. Chan +11 more
2023Clinical Cancer Research20 citations Open access
Semantic Scholar
Vol-PACT: A Foundation for the NIH Public-Private Partnership That Supports Sharing of Clinical Trial Data for the Development of Improved Imaging Biomarkers in Oncology.
L. Dercle, Dana E. Connors, Ying Tang, S. Adam +9 more
2018JCO Clinical Cancer Informatics20 citations Open access
Semantic Scholar
An imaging signature to predict outcome in metastatic colorectal cancer using routine CT scans
L. Dercle, Binsheng Zhao, M. Gönen, C. Moskowitz +9 more
2021European Journal of Cancer19 citations Open access
Semantic Scholar
A Pharmacodynamic Study of Sirolimus and Metformin in Patients with Advanced Solid Tumors
A. Sehdev, T. Karrison, Y. Zha, L. Janisch +11 more
2018Cancer Chemotherapy and Pharmacology17 citations Open access
Semantic Scholar
A phase 1 study of PF-06647020, an antibody-drug conjugate (ADC) targeting protein tyrosine kinase 7 (PTK7), in patients with advanced solid tumors including platinum resistant ovarian cancer (OVCA)
J. Sachdev, M. Maitland, Manish R. Sharma, V. Moreno +11 more
201616 citations Open access
Semantic Scholar
Time to tumor growth: a model end point and new metric system for oncology clinical trials.
M. Maitland, L. Schwartz, M. Ratain
2013Journal of Clinical Oncology15 citations Open access
Semantic Scholar
Models of Excellence: Improving Oncology Drug Development
Manish R. Sharma, M. Maitland, M. Ratain
2012Clinical pharmacology and therapy15 citations Open access
Semantic Scholar
A time to keep and a time to cast away categories of tumor response.
M. Maitland, R. Bies, J. Barrett
2011Journal of Clinical Oncology15 citations
Semantic Scholar
Estimation of renal cell carcinoma treatment effects from disease progression modeling
M. Maitland, Ke-Hua Wu, Manish R. Sharma, Yu-Yan Jin +5 more
2012Clinical pharmacology and therapy14 citations Open access
Semantic Scholar
Comparison of tumor size assessments in tumor growth inhibition-overall survival models with second-line colorectal cancer data from the VELOUR study
L. Claret, Christina Pentafragka, S. Karovic, Binsheng Zhao +3 more
2018Cancer Chemotherapy and Pharmacology13 citations
Semantic Scholar
Bayesian inference for longitudinal data with non-parametric treatment effects.
P. Müller, F. Quintana, G. Rosner, M. Maitland
2014Biostatistics12 citations Open access
Semantic Scholar
Effects of vascular endothelial growth factor signaling inhibition on human erythropoiesis.
S. Bhatta, K. Wroblewski, K. Agarwal, L. Sit +7 more
2013The Oncologist12 citations Open access
Semantic Scholar
Volumes to learn: advancing therapeutics with innovative CT image data analysis
M. Maitland
2010Clinical Cancer Research12 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Ratain×18
Invite
M. Ratain — researcher profile on SciRah
Manish R. Sharma×9
Invite
Manish R. Sharma — researcher profile on SciRah
T. Karrison×8
Invite
T. Karrison — researcher profile on SciRah
S. Karovic×7
Invite
S. Karovic — researcher profile on SciRah

×6

Invite

A. Tolcher — researcher profile on SciRah

Invite

L. Schwartz — researcher profile on SciRah

Invite

L. Janisch — researcher profile on SciRah

Invite

Ke-Hua Wu — researcher profile on SciRah

Binsheng Zhao×5

Invite

Binsheng Zhao — researcher profile on SciRah

Invite

S. Undevia — researcher profile on SciRah

Invite

R. Schilsky — researcher profile on SciRah

Invite

J. Ramírez — researcher profile on SciRah